Rebecca Boohaker joined Southern Research in 2013 to complete her postdoctoral fellowship. In 2016, she became a research assistant fellow in the Oncology Department within the Drug Discovery division. She is currently interested in investigating the processes by which cancer cells exploit their own regulatory machinery to promote tumorigenesis as means to develop novel therapeutics.
Boohaker spent her graduate education focused on the interdisciplinary study of the structure and function of proteins involved in apoptosis. This resulted in the development of a therapeutic peptide derived from the Bcl-2 family protein Bax. Her interests have broadened to include cell cycle regulation and the DNA damage response, as well as overcoming tumor-induced immune evasion.
She graduated from the University of Alabama at Birmingham with a degree in Biology and a minor in Chemistry. Boohaker attended the University of Central Florida in Orlando where she earned her doctorate.